# Hydrolyzed collagen-modified bacterial cellulose loaded with tea tree oil for antibacterial activity against acne-associated bacteria

**Authors:** Taiwo Salawudeen, Juntratip Jomrit, Sirikanya Kaewpradit, Nuttikarn Nokkaew, Chutima Jantarat

PMC · DOI: 10.1039/d5ra09816e · RSC Advances · 2026-02-17

## TL;DR

A new delivery system using bacterial cellulose modified with hydrolyzed collagen effectively enhances tea tree oil's antibacterial properties for treating acne.

## Contribution

The study introduces a novel biopolymer-based delivery system using hydrolyzed collagen-modified bacterial cellulose to improve tea tree oil's stability and antibacterial efficacy.

## Key findings

- In situ modification of bacterial cellulose with hydrolyzed collagen increased TTO loading efficiency up to eightfold.
- TTO-loaded composites showed potent antibacterial activity against acne-associated bacteria with no detectable colonies within 2–3 hours.
- The composites retained over 70% antibacterial activity after three months of storage, outperforming conventional substrates.

## Abstract

Acne is a chronic inflammatory skin disorder commonly treated with topical antibiotics, whose long-term use is limited by antimicrobial resistance and adverse effects. Tea tree oil (TTO) is a natural antimicrobial agent effective against acne-associated bacteria; however, its clinical application is hindered by volatility, oxidative instability, and skin irritation at high concentrations. In this study, a novel biopolymer-based delivery system was developed using bacterial cellulose modified with hydrolyzed collagen (BC/HC) to enhance the loading, stability, and antibacterial efficacy of TTO for potential acne therapy. BC/HC composites were prepared via both in situ and ex situ collagen modification approaches and comprehensively characterized for their physicochemical properties. In situ modification significantly reduced crystallinity (from ∼81% in native BC to ∼76% at the highest HC content), increased porosity, and improved water-holding capacity, resulting in markedly enhanced TTO loading efficiency-up to eightfold compared with unmodified BC when loaded in the swollen state. The TTO-loaded BC/HC composites exhibited a desirable biphasic release profile with an initial burst followed by sustained release. Concentration-dependent antibacterial activity against Staphylococcus aureus and Cutibacterium acnes was demonstrated through disc diffusion and time-kill kinetic assays, which showed no detectable colonies within 2–3 h at the highest TTO loadings. Stability studies showed that high terpinen-4-ol content (>90%) and approximately 70% antibacterial activity were retained after three months under both normal and accelerated storage conditions for composites with high TTO loading, significantly outperforming conventional substrates. Overall, in situ HC-modified BC represents a promising, natural, and sustainable delivery platform for TTO, offering enhanced loading capacity, controlled release, potent antibacterial activity, and improved stability, with strong potential as a topical antimicrobial platform active against acne-associated bacteria.

Preparation and antibacterial evaluation of TTO-loaded BC/HC composites.

## Linked entities

- **Chemicals:** terpinen-4-ol (PubChem CID 11230)
- **Diseases:** acne (MONDO:0011438)
- **Species:** Staphylococcus aureus (taxon 1280), Cutibacterium acnes (taxon 1747)

## Full-text entities

- **Diseases:** anxiety (MESH:D001007), WHC (MESH:D000069578), irritation (MESH:D001523), skin disorder (MESH:D012871), pain (MESH:D010146), inflammation (MESH:D007249), wound infections (MESH:D014946), dermatological disorders (MESH:D000168), Acne (MESH:D000152), depression (MESH:D003866), HC (MESH:D003095), BC (MESH:D001424), dryness (MESH:D014987)
- **Chemicals:** carbon (MESH:D002244), agar (MESH:D000362), HC (MESH:D006854), cellulose acetate (MESH:C005062), nitrogen (MESH:D009584), alpha-terpineol (MESH:C016775), Ni (MESH:D009532), oxygen (MESH:D010100), gold (MESH:D006046), Terpinen-4-ol (MESH:C034019), sodium hydroxide (MESH:D012972), amoxicillin (MESH:D000658), EtOH (MESH:D000431), erythromycin (MESH:D004917), RH (MESH:D012238), essential oil (MESH:D009822), retinoids (MESH:D012176), terpene (MESH:D013729), alpha-terpinene (MESH:C018669), CLI (MESH:D002981), Water (MESH:D014867), monoterpene (MESH:D039821), oil (MESH:D009821), beta-1,4-glucan (MESH:C040088), disodium hydrogen phosphate (MESH:C018279), hexane (MESH:D006586), Helium (MESH:D006371), BC (-), terpinolene (MESH:C027009), aluminum (MESH:D000535), glucose (MESH:D005947), bacitracin (MESH:D001414), cellulose (MESH:D002482), hydrogen (MESH:D006859), TTO (MESH:D020947), lipids (MESH:D008055), citric acid (MESH:D019343), benzoyl peroxide (MESH:D001585)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Komagataeibacter xylinus (species) [taxon 28448], Escherichia coli (E. coli, species) [taxon 562], Cutibacterium acnes (species) [taxon 1747], Melaleuca alternifolia (tea tree, species) [taxon 164405], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Staphylococcus aureus (species) [taxon 1280]
- **Cell lines:** ATCC 25922 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), DMST 14916 — Homo sapiens (Human), Transformed cell line (CVCL_GL64)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910439/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12910439/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12910439/full.md

---
Source: https://tomesphere.com/paper/PMC12910439